2.15

0.47% +0.010

After Hours: 2.09 -0.06 -2.79%

ETFMG U.S. Alternative Harvest ETF (MJUS)

Overview News Price History Discussions Forecast

ETFMG U.S. Alternative Harvest ETF stock is currently priced at $2.15, with a 24-hour trading volume of 12.53M. It has seen a +0.47% increased in the last 24 hours and a +4.88% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.16 pivot point. If it approaches the $2.08 support level, significant changes may occur.

Previous Close:

$2.14

Open:

$2.16

24h Volume:

12.53M

Market Cap:

$N/A

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+5.84%

1M Performance:

+4.88%

6M Performance:

+30.30%

1Y Performance:

+48.28%

1D Range:

$2.07

$2.1653

52W Range:

$1.29

$2.45

ETFMG U.S. Alternative Harvest ETF Stock (MJUS) Company Profile

Name

ETFMG U.S. Alternative Harvest ETF

Sector

Financial (4627)

Industry

Exchange Traded Fund (3096)

Phone

(877) 756-PURE

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

MJUS's Discussions on Twitter

ETFMG U.S. Alternative Harvest ETF Stock (MJUS) Latest News

Cboe Global Markets surpasses 1,000 ETFs worldwide - The Globe and Mail

The Globe and Mail

The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail

The Globe and Mail

Hong Kong Approves First Bitcoin and Ether ETFs: A Game-Changer in the Crypto Market - The Globe and Mail

The Globe and Mail

Marijuana ETFs Breezing Past S&P 500: More Growth Ahead?

Zacks Investment Research

These 'High' Flying Stocks Smoke The Magnificent Seven - Investor's Business Daily

Investor's Business Daily

Understanding Cannabis ETFs’ Wacky Divergence - ETF Trends

ETF Trends

ETFMG U.S. Alternative Harvest ETF Stock (MJUS) Financials Data

There is no financial data for ETFMG U.S. Alternative Harvest ETF (MJUS). Check out other stocks for more information.

The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the “Cannabis Business” in the United States, and in derivatives that have economic characteristics similar to such securities. It will will concentrate at least 25% of its investments in the Pharmaceuticals industry and Equity Real Estate Investment Trusts (REITs) industry groups. The fund is non-diversified.